Cargando…
Adverse Event Burden, Resource Use, and Costs Associated with Immunosuppressant Medications for the Treatment of Systemic Lupus Erythematosus: A Systematic Literature Review
This paper assessed the burden of adverse events (AEs) associated with azathioprine (AZA), cyclophosphamide (CYC), mycophenolate mofetil (MMF), methotrexate (MTX), and cyclosporine (CsA) in patients with systemic lupus erythematosus (SLE). Thirty-eight publications were included. Incidence of AEs ra...
Autores principales: | Oglesby, A., Shaul, A. J., Pokora, T., Paramore, C., Cragin, L., Dennis, G., Narayanan, S., Weinstein, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638708/ https://www.ncbi.nlm.nih.gov/pubmed/23762067 http://dx.doi.org/10.1155/2013/347520 |
Ejemplares similares
-
Postoperative Major Adverse Cardiac Events in Patients With Systemic Lupus Erythematosus
por: Bruera, Sebastian, et al.
Publicado: (2022) -
Adverse Outcomes, Healthcare Resource Utilization, and Costs Associated with Systemic Corticosteroid use Among Adults with Systemic Lupus Erythematosus in the UK
por: Stirnadel-Farrant, Heide A., et al.
Publicado: (2023) -
The Burden of Systemic Lupus Erythematosus in Germany: Incidence, Prevalence, and Healthcare Resource Utilization
por: Schwarting, Andreas, et al.
Publicado: (2021) -
Brain paracoccidioidomycosis in an immunosuppressed patient with systemic lupus erythematosus
por: Kamer, Carolina, et al.
Publicado: (2021) -
Dilemma of immunosuppression and infection risk in systemic lupus erythematosus
por: He, Jing, et al.
Publicado: (2023)